Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$17.02 - $21.0 $288,420 - $355,866
16,946 New
16,946 $309,000
Q4 2023

Feb 14, 2024

BUY
$19.02 - $30.13 $973,824 - $1.54 Million
51,200 New
51,200 $1.14 Million
Q2 2020

Aug 14, 2020

SELL
$9.68 - $17.5 $194,568 - $351,750
-20,100 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$7.43 - $24.88 $33,435 - $111,960
4,500 Added 28.85%
20,100 $432,000
Q4 2019

Feb 14, 2020

BUY
$11.01 - $27.92 $7,497 - $19,013
681 Added 4.56%
15,600 $612,000
Q3 2019

Nov 13, 2019

BUY
$6.79 - $14.24 $101,300 - $212,446
14,919 New
14,919 $321,000

Others Institutions Holding INMD

About InMode Ltd.


  • Ticker INMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 83,081,104
  • Market Cap $1.45B
  • Description
  • InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedur...
More about INMD
Track This Portfolio

Track Bayesian Capital Management, LP Portfolio

Follow Bayesian Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bayesian Capital Management, LP with notifications on news.